Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
Re-biopsy and EGFR mutation analysis
Ask a
question
Favorite
When disease had progressed, re-biopsy was recommended. The EGFR genotypes of re-biopsied materials were analyzed at each hospital using the peptide nucleic acid-locked nucleic acid clamp method (16) or the cobas® EGFR Mutation Test v2.
Copyright and License information: ©2019 The Author(s) 2019. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact moc.puo@snoissimrep.slanruoj
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
